Cancer Institute

Research projects (9)

Cyberknife CT

Cyberknife Accelerated Partial Breast Irradiation

Improving the accuracy of the Cyberknife Accelerated Partial Breast Irradiation (CK-APBI) technique for postoperative radiotherapy for early-stage breast cancer

Research project default image

DPOG TDM Study

During this project we will implement therapeutic drug monitoring of oral targeted anti-cancer drugs to personalize the given treatment for each individual

Research project default image

MIRACLE

Colorectal cancer patients often develop surgically removable liver metastases. We aim to develop a test to identify patients in need of additional treatment.

Research project default image

MULTOMAB

The objective of the MULTOMAB study is to set up a bank of prospectively collected blood samples for pharmacokinetic analyses of monoclonal antibodies

default image of Erasmus MC research projects

OnVaCT study

We are developing and evaluating an Online Value Clarification Tool (OnVaCT) to assist patients in clarifying their values around the decision to participate in early phase clinical trials (or not).

default image of Erasmus MC research projects

Predicting 1-year mortality for patients with advanced cancer and patients with chronic obstructive pulmonary disease

In this study, clinical models are developed to predict 1-year mortality for patients with advanced cancer and patients with chronic obstructive pulmonary disease.

default image of Erasmus MC research projects

Silence study

In this study, the prophylactic effect of scopolamine butyl is investigated on death rattle in a double blind placebo-controlled randomized study

default image of Erasmus MC research projects

The Radiotherapy Optimisation Test Set (TROTS)

TROTS is an extensive set of problems originating from radiotherapy treatment planning to objectively compare optimisation approaches amongst institutes

Research project default image

TOTAM

Therapeutic Drug Monitoring guided tamoxifen dosing: a feasibility study in patients with hormone positive breast cancer